Skip to main content
SpringerLink
Log in

Morbidity in Compromised Patients Related to Viruses Other Than Herpes Group and Hepatitis Viruses

  • Chapter
Clinical Approach to Infection in the Compromised Host

  • 69 Accesses

Abstract

The past decade has witnessed greatly increased awareness of the multiple roles played by viral agents in immunocompromised patients. This interest, which has been stimulated by the development of effective antiviral chemotherapy for herpes group viruses, in particular, has been greatly facilitated by the development of more direct approaches to diagnosis using molecular biologic and monoclonal antibody technology. Lessened reliance on standard serologic techniques for viral diagnosis has been especially useful in immunocompromised patients in whom humoral responses may be delayed or absent.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chanock RM: Impact of adenovirus in human disease. Prev Med 3: 466–472, 1974.

    Article  PubMed  CAS  Google Scholar 

  2. Zahradnik JM, Spencer MJ, Parker DD: Adenovirus infection in the immunocompromised patient. Am J Med 68: 725–732, 1980.

    Article  PubMed  CAS  Google Scholar 

  3. Carmichael GP, Zahradnik JM, Moyer GM, et al: Adenovirus hepatitis in an immunosuppressed adult patient. Am J Clin Paihol 71: 352–355, 1979.

    Google Scholar 

  4. Rodriguez FH, Liuzza GE, Gohd RH: Disseminated adenovirus serotype 31 infection in an immunocompromised host. Am J Clin Pathol 82: 615–618, 1979.

    Google Scholar 

  5. Myerowitz RL, Stadler H, Oxman MN, et al: Fatal disseminated adenovirus infection in a renal transplant recipient. Am J Med 59: 591–598, 1975.

    Article  PubMed  CAS  Google Scholar 

  6. Michaels MG, Green M, Wald ER, et al: Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 165: 170–174, 1992.

    Article  PubMed  CAS  Google Scholar 

  7. Salt A, Sutehall G, Sargaison M, et al: Viral and Toxoplasma gondii infections in children after liver transplantation. J Clin Pathol 43: 63–67, 1990.

    Article  PubMed  CAS  Google Scholar 

  8. Wasserman R, August CS, Plotkin SA: Viral infections in pediatric bone marrow transplant patients. Pediatr Infect Dis J 7: 109–115, 1988.

    Article  PubMed  CAS  Google Scholar 

  9. Strickler JG, Singleton TP, Copenhaver CM, et al: Adenovirus in the gastrointestinal tracts of immunosuppressed patients. Am J Clin Pathol 97: 555–558, 1992.

    PubMed  CAS  Google Scholar 

  10. Wreghitt TG, Gray JJ, Ward KN, et al: Disseminated adenovirus infection after liver transplantation and its possible treatment with ganciclovir (letter). J Infect 19: 88–89, 1989.

    Article  PubMed  CAS  Google Scholar 

  11. Norris SH, Butler TC, Glass N, et al: Fatal hepatic necrosis caused by disseminated type 5 adenovirus infection in a renal transplant recipient. Am J Nephrol 9: 101–105, 1989.

    Article  PubMed  CAS  Google Scholar 

  12. Janner D, Petru AM, Belchis D, et al: Fatal adenovirus infection in a child with acquired immunodeficiency syndrome (see comments). Pediatr Infect Dis J 9: 434–436, 1990.

    Article  PubMed  CAS  Google Scholar 

  13. Johnson PR, Yin JA, Morris DJ, et al: Fulminant hepatic necrosis caused by adenovirus type 5 following bone marrow transplantation. Bone Marrow Transplant 5: 345–347, 1990.

    PubMed  CAS  Google Scholar 

  14. Ljungman P, Ehrnst A, Bjorkstrand B, et al: Lethal disseminated adenovirus type 1 infection in a patient with chronic lymphocytic leukemia. Scand J Infect Dis 22: 601–605, 1990.

    Article  PubMed  CAS  Google Scholar 

  15. Keller EW, Rubin RH, Black PH, et al: Isolation of adenovirus type 34 from a renal transplant recipient with interstitial pneumonia. Transplantation 23: 188–191, 1977.

    Article  PubMed  CAS  Google Scholar 

  16. Neiman PE, Reeves W, Ray G, et al: A prospective analysis of interstitial pneumonia and opportunistic viral infections among recipients of allogeneic bone marrow grafts. J Infect Dis 136: 754–767, 1977.

    Article  PubMed  CAS  Google Scholar 

  17. Lecatsas G, Van Wyk JAC: DNA viruses in urine after renal transplantation. S Afr Med J 53: 787–788, 1978.

    PubMed  CAS  Google Scholar 

  18. Wigger HJ, Blanc WA: Fatal hepatic and bronchial necrosis in adenovirus infection with thymic alymphoplasia. N Engl J Med 275: 870–874, 1968.

    Article  Google Scholar 

  19. Dagan R, Schwartz RH, Insel RA, et al: Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: Possible therapeutic effect of human serum immune globulin containing specific neutralizing antibody. Pediatr Infect Dis 3: 246–249, 1984.

    Article  PubMed  CAS  Google Scholar 

  20. Siegal FP, Dikman SH, Arayatu RB, et al: Fatal disseminated adenovirus pneumonia in an agammaglobulinemic patient. Am J Med 71: 1062–1067, 1981.

    Article  PubMed  CAS  Google Scholar 

  21. Shields AF, Hackman RC, Fife HK, et al: Adenovirus infection in patients undergoing bone marrow transplantation. N Engl J Med 312: 529–533, 1985.

    Article  PubMed  CAS  Google Scholar 

  22. Valteau D, Hartmann O, Benhamou E, et al: Nonbacterial nonfungal interstitial pneumonitis following autologous bone marrow transplantation in children treated with high-dose chemotherapy without total-body irradiation. Transplantation 45: 737–740, 1988.

    Article  PubMed  CAS  Google Scholar 

  23. Yolken RH, Bishop CA, Townsend TR, et al: Infectious gastroenteritis in bone marrow transplant recipients. N Engl J Med 306: 1009–1012, 1982.

    Article  Google Scholar 

  24. Johansson ME, Wirgart BZ, Grillner L, et al: Severe gastroenteritis in an immunocompromised child caused by adenovirus type 5. Pediatr Infect Dis J 9: 449–450, 1990.

    Article  PubMed  CAS  Google Scholar 

  25. Janoff EN, Orenstein JM, Manischewitz JF, et al: Adenovirus colitis in the acquired immunodeficiency syndrome. Gastroenterology 100: 976–979, 1991.

    PubMed  CAS  Google Scholar 

  26. Okano M, Thiele GM, Davis JR, et al: Adenovirus type-2 in a patient with lethal hemorrhagic colonic ulcers and chronic active Epstein-Barr virus infection. Ann Intern Med 108: 693–699, 1988.

    PubMed  CAS  Google Scholar 

  27. deJong PJ, Valderrama G, Spigland I, et al: Adenovirus isolates from urine of patients with acquired immunodeficiency syndrome. Lancet 1: 1293–1296, 1983.

    Article  CAS  Google Scholar 

  28. Horwitz MS, Valderrama G, Hatcher V, et al: Characterization of adenovirus isolates from AIDS patients. Ann NY Acad Sci 437: 161–174, 1984.

    Article  PubMed  CAS  Google Scholar 

  29. Hierholzer JC, Wigand R, Anderson LJ, et al: Adenoviruses from patients with AIDS. A plethora of serotypes and a description of five new serotypes of subgenus D types (types 43–47). J Infect Dis 154: 804–813, 1988.

    Article  Google Scholar 

  30. Valainis GT, Carlisle JT, Daroca PJ, et al: Respiratory failure complicated by adenovirus type 29 in a patient with AIDS. J Infect Dis 160: 349–351, 1989.

    Article  PubMed  CAS  Google Scholar 

  31. Lecatsas G, Prozesky OW, Van Wyk J: Adenovirus type 11 associated with hemorrhagic cystitis after renal transplantation. S Afr Med J 48: 1932–1935, 1974.

    PubMed  CAS  Google Scholar 

  32. Cassano WF: Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant 7: 247–248, 1991.

    PubMed  CAS  Google Scholar 

  33. Buchanan W, Bowman JS, Jaffers G: Adenoviral acute hemorrhagic cystitis following renal transplantation (letter). Am J Nephrol 10: 350–351, 1990.

    Article  PubMed  CAS  Google Scholar 

  34. Yagisawa T, Takahashi K, Yamaguchi Y, et al: Adenovirus induced nephropathy in kidney transplant recipients. Transplant Proc 21: 2097–2099, 1989.

    PubMed  CAS  Google Scholar 

  35. Ambinder R, Burns W, Forman M, et al: Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. Arch Intern Med 146: 1400–1401, 1986.

    Article  PubMed  CAS  Google Scholar 

  36. Miyamura K, Takeyama K, Kojima S, et al: Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation. Bone Marrow Transplant 4: 533–535, 1989.

    PubMed  CAS  Google Scholar 

  37. Teague MW, Glick AD, Fogo AB: Adenovirus infection of the kidney: Mass formation in a patient with Hodgkin’s disease. Am J Kidney Dis 18: 499–502, 1991.

    PubMed  CAS  Google Scholar 

  38. Chou SM, Roos R, Burrell R, et al: Subacute focal adenovirus encephalitis. J Neuropathol Exp Neurol 32: 34–50, 1973.

    Article  PubMed  CAS  Google Scholar 

  39. Lau YL, Levinsky RJ, Morgan G, et al: Dual meningoencephalitis with echovirus type 11 and adenovirus in combined (common variable) immunodeficiency. Pediatr Infect Dis J 7: 873–876, 1988.

    PubMed  CAS  Google Scholar 

  40. Davis D, Henslee PJ, Markesbery WR: Fatal adenovirus meningoencephalitis in a bone marrow transplant patient. Ann Neurol 23: 385–389, 1988.

    Article  PubMed  CAS  Google Scholar 

  41. Coldiron BM, Freeman RG, Beaudoing DL: Isolation of adenovirus from a granuloma annulare-like lesion in the acquired immunodeficiency syndrome-related complex. Arch Dermatol 124: 654–655, 1988.

    Article  PubMed  CAS  Google Scholar 

  42. Levy J, Wodell RA, August CS, et al: Adenovirus-related hemophagocytic syndrome after bone marrow transplantation. Bone Marrow Transplant 6: 349–352, 1990.

    PubMed  CAS  Google Scholar 

  43. Bayon MN, Drut R: Cytologic diagnosis of adenovirus bronchopneumonia. Acta Cytol 35: 181–182, 1991.

    PubMed  CAS  Google Scholar 

  44. Mahafzal Am, Landry ML: Evaluation of immunofluorescent reagents, centrifugation, and conventional cultures for the diagnosis of adenovirus infection. Diagn Microbiol Infect Dis 12: 407–411, 1989.

    Article  Google Scholar 

  45. Wood DJ, Bijlsma K, deJong JC, et al: Evaluation of a commercial monoclonal antibody-based enzyme immunoassay for detection of adenovirus types 40 and 41 in stool specimens. J Clin Microbiol 27: 1155–1158, 1989.

    PubMed  CAS  Google Scholar 

  46. Allard A, Girones R, Juto P, et al: Polymerase chain reaction for detection of adenoviruses in stool samples [published erratum appears in J Clin Microbiol 29: 2683]. J Clin Microbiol 28: 2659–2667, 1990.

    PubMed  CAS  Google Scholar 

  47. Gordon YJ, Romanowski E, Araullo-Cruz T, et al: Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2′-non-cyclic GMP on clinical ocular adenovirus isolates is serotype-dependent in vitro. Antiviral Res 16: 11–16, 1991.

    Article  PubMed  CAS  Google Scholar 

  48. Shah KV, Daniel RW, Warszawski RM: High prevalence of antibodies of BK virus, on SV 40 related papovavirus, in residents of Maryland. J Infect Dis 127: 784–787, 1973.

    Article  Google Scholar 

  49. Padgett B, Walker D: Natural history of human polyomavirus infections. In Stevens JG, Todaro GJ, Fox CF (eds): Persistent Viruses. Academic, New York, 1978, pp. 751–758.

    Google Scholar 

  50. Shah KV, Daniel RW, Zeigel KK, and Murphy GP: Search for BK and SV 40 virus reactivation in renal transplant recipients. Transplantation 17: 131–134, 1974.

    Article  PubMed  CAS  Google Scholar 

  51. Astrom KE, Mancall EL, Richardson EP Jr: Progressive multifo-cal leukoencephalopathy: hitherto unrecognized complication of chronic lymphatic leukemia and Hodgkin’s disease. Brain 81: 93–111, 1958.

    Article  PubMed  CAS  Google Scholar 

  52. Gillespie SM, Chang Y, Lemp G, et al: Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981–89. Ann Neurol 30: 597–604, 1991.

    Article  PubMed  CAS  Google Scholar 

  53. Richardson EP Jr: Progressive multifocal leukoencephalopathy. N Engl J Med 265: 815–823, 1961.

    Article  PubMed  Google Scholar 

  54. ZuRhein GM, Chow SM: Particles resembling papovaviruses in human cerebral demyelinating disease. Science 148: 1477–1479, 1965.

    Article  PubMed  CAS  Google Scholar 

  55. Padgett BL, Walker DL, ZuRhein GM, et al: Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1: 1257–1260, 1971.

    Article  PubMed  CAS  Google Scholar 

  56. Weiner LP, Heradon RM, Narayan O, et al: Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med 286: 385–390, 1972.

    Article  PubMed  CAS  Google Scholar 

  57. Hogan T, Borden E, McBain J, et al: Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 92: 373–378, 1980.

    PubMed  CAS  Google Scholar 

  58. Coleman D, Wolfendale M, Daniel R, et al: A prospective study of human polyomavirus infection in pregnancy. J Infect Dis 142: 1–8, 1980.

    Article  PubMed  CAS  Google Scholar 

  59. Arthur RR, Dagostin S, Shah KV: Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction. J Clin Microbiol 27: 1174–1179, 1989.

    PubMed  CAS  Google Scholar 

  60. Mori M, Aoki N, Shimada H, et al: Defection of JC virus in the brains of aged patients without progressive multifocal leukoencephalopathy by the polymerase chain reaction and Southern hybridization analysis. Neurosci Lett 41: 151–155, 1992.

    Article  Google Scholar 

  61. Myers C, Frisque RJ, Arthur RR: Direct isolation and characterization of JC virus from urine samples of renal and bone marrow transplant patients. J Virol 63: 4445–4449, 1989.

    PubMed  CAS  Google Scholar 

  62. Lyon LW, McCormick WF, Schochet SS Jr: Progressive multifocal leukoencephalopathy. Neurology (NY) 21: 72–77, 1971.

    Google Scholar 

  63. Horte-Barbosa L, Hamilton R, Fucillo DA, et al: Progressive multifocal leukoencephalopathy. N Engl J Med 286: 1060, 1972.

    Google Scholar 

  64. Eisner C, Domes K: Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology 191: 72–80, 1992.

    Article  Google Scholar 

  65. Quinlivan EB, Norris M, Bouldin TW, et al: Subclinical central nervous system infection with JC virus in patients with AIDS. J Infect Dis 166: 80–85, 1992.

    Article  PubMed  CAS  Google Scholar 

  66. White FA 3d, Ishaq M, Stoner GL, et al: JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol 66: 5726–5734, 1992.

    PubMed  Google Scholar 

  67. Miller JR, Barrett RE, Britton CB: Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. N Engl J Med 307: 1436–1438, 1982.

    Article  PubMed  CAS  Google Scholar 

  68. Snider WD, Simpson DM, Nielsen S, et al: Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients. Ann Neurol 14: 403–417, 1983.

    Article  PubMed  CAS  Google Scholar 

  69. Levy RM, Bredesen ED, Rosenblum ML: Neurological manifestation of the acquired immune deficiency syndrome (AIDS): Experience at UCSF and the review of the literature. J Neurosurg 62: 475–495, 1985.

    Article  PubMed  CAS  Google Scholar 

  70. Shaw GM, Harper ME, Hahn BH. et al: HTLV-III infection in brains of children and adults with AIDS Encephalopathy. Science 227: 177–181, 1985.

    Article  PubMed  CAS  Google Scholar 

  71. Ho DD, Rota TR, Schooley RT, et al: Isolation of HTLV-III from CSF and neural tissues of patients with AIDS related neurological syndromes. N Engl J Med 313: 1493–1497, 1985.

    Article  PubMed  CAS  Google Scholar 

  72. Tada H, Rappaport J, Lashgari M, et al: Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci USA 87: 3479–3483, 1991.

    Article  Google Scholar 

  73. Petito CK, Navia BA, Cho E-S, et al: Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immune deficiency syndrome. N Engl J Med 312: 874–879, 1985.

    Article  PubMed  CAS  Google Scholar 

  74. Hogan TF, Borden EC, McBain JA, et al: Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 92: 373–378, 1980.

    PubMed  CAS  Google Scholar 

  75. Woodhouse MA, Dayan AD, Burston J, et al: Progressive multifocal leukoencephalopathy: Electron microscope study of four cases. Brain 90: 863–870, 1967.

    Article  PubMed  CAS  Google Scholar 

  76. Teo CG, Wong SY, Best PV: JC virus genomes in progressive multifocal leukoencephalopathy: Detection using a sensitive non-radioisotopic in situ hybridization method. J Pathol 157: 135–140, 1989.

    Article  PubMed  CAS  Google Scholar 

  77. Boerman RH, Arnoldus EP, Raap AK, et al: Diagnosis of progressive multifocal leukoencephalopathy by hybridization techniques. J Clin Pathol 42: 153–161, 1989.

    Article  PubMed  CAS  Google Scholar 

  78. Houff SA, Katz D, Kufta CV, et al: A rapid method for in situ hybridization for viral DNA in brain biopsies from patients with AIDS. AIDS 3: 843–845, 1989.

    Article  PubMed  CAS  Google Scholar 

  79. Hulette CM, Downey BT, Burger PC: Progressive multifocal leukoencephalopathy. Diagnosis by in situ hybridization with a biotinylated JC virus DNA probe using an automated Histomatic Code-On slide stainer. Am J Surg Pathol 15: 791–797, 1991.

    Article  PubMed  CAS  Google Scholar 

  80. Schmidbauer M, Budka H, Shah KV: Progressive multifocal leukoencephalopathy (PML) in AIDS and in the pre-AIDS era. A neuropathological comparison using immunocytochemistry and in situ DNA hybridization for virus detection. Acta Neuropathol 80: 375–380, 1990.

    Article  PubMed  CAS  Google Scholar 

  81. Knowles WA, Sharp IR, Efstratiou L, et al: Preparation of monoclonal antibodies to JC virus and their use in the diagnosis of progressive multifocal leukoencephalopathy. J Med Virol 34: 127–131, 1991.

    Article  PubMed  CAS  Google Scholar 

  82. Telenti A, Aksamit AJ Jr, Proper J, et al: Detection of JC virus DNA by polymerase chain reaction in patients with progressive multifocal leukoencephalopathy. J Infect Dis 162: 858–861, 1990.

    Article  PubMed  CAS  Google Scholar 

  83. Henson J, Rosenblum M, Armstrong D, et al: Amplification of JC virus DNA from brain and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. Neurology 41: 1967–1971, 1991.

    PubMed  CAS  Google Scholar 

  84. Brouqui P, Bollet C, Delmont J, et al: Diagnosis of progressive multifocal leukoencephalopathy by PCR detection of JC virus from CSF (letter). Lancet 339: 1182, 1992.

    Article  PubMed  CAS  Google Scholar 

  85. Kitamura T, Aso Y, Kuniyoshi N, et al: High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J Infect Dis 161: 1128–1133, 1990.

    Article  PubMed  CAS  Google Scholar 

  86. Tornatore C, Berger JR, Houff SA, et al: Detection of JC virus DNA in peripheral multifocal leukoencephalopathy. Ann Neurol 31: 454–462, 1992.

    Article  PubMed  CAS  Google Scholar 

  87. ZuRhein GM, Varakis J: Progressive multifocal luekoencephalopathy in a renal allograft recipient. N Engl J Med 291: 798, 1974.

    PubMed  CAS  Google Scholar 

  88. Bauer WR, Turel AP, Johnson KP: Progressive multifocal leukoencephalopathy and cytarabine: Remission with treatment. JAMA 226: 174–176, 1973.

    Article  PubMed  CAS  Google Scholar 

  89. Smith CR, Sima AAF, Salit IE, et al: Progressive multifocal leukoencephalopathy: Failure of cytarabine therapy. Neurology (NY) 32: 200–203, 1982.

    CAS  Google Scholar 

  90. Conomy JP, Beard NS, Matsumoto H, et al: Cytarabine treatment of PML. JAMA 229: 1313–1316, 1974.

    Article  PubMed  CAS  Google Scholar 

  91. VanHorn G, Bastian FO, Moate JL: Progressive multifocal leukoencephalopathy: Failure of response to transfer factor and cytarabine. Neurology (NY) 28: 744–747, 1978.

    Google Scholar 

  92. Peters ACB, Vertsteeg J, Bots GTA, et al: Progressive multifocal leukoencephalopathy: Immunofluorescent demonstration of SV 40 antigen on CSF cells and response to cytarabine therapy. Arch Neurol 37: 497–501, 1980.

    Article  PubMed  CAS  Google Scholar 

  93. Rand RH, Johnson KP, Rubenstein LJ, et al: Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: Use of virus containing cells in the urine to assess response to therapy. Ann Neurol 1: 458–462, 1977.

    Article  PubMed  CAS  Google Scholar 

  94. Rockwell D, Ruben FL, Windlestein A, et al: Absence of immune deficiency in a case of progressive multifocal leukoencephalopathy. Am J Med 61: 433–436, 1976.

    Article  PubMed  CAS  Google Scholar 

  95. Marriott PS, O’Brien MD, MacKenzie IC, et al: Progressive multifocal leukoencephalopathy: Remission with cytarabine. J Neurol Neurosurg Psychiatry 38: 205–209, 1975.

    Article  PubMed  CAS  Google Scholar 

  96. Castleman G, Scully RE, McNeeley BU: Clinicopathological conference. N Engl J Med 286: 1047–1054, 1972.

    Article  Google Scholar 

  97. Tarsy D, Holden EM, Segarra JM, et al: 5-Iodo-2′-deoxyuridine given intraventricularly in the treatment of progressive multifocal leukoencephalopathy. Cancer Chemother Rep 57: 73–78, 1973.

    PubMed  CAS  Google Scholar 

  98. Hedley Whyte ET, Smith BP, Tyler HR, et al: Multifocal leukoencephalopathy with remission and five year survival. J Neuropathol Exp Neurol 25: 107–116, 1966.

    Article  Google Scholar 

  99. Holden EM, Tarsy D, Calabresi P, et al: Use of 5-iodo-2′-deoxyuridine in progressive multifocal leukoencephalopathy. Neurology (NY) 21: 448, 1971.

    Google Scholar 

  100. Tashiro K, Doi S, Moriwaka F, et al: Progressive multifocal leukoencephalopathy with magnetic resonance imaging verification and therapeutic trials with interferon. J Neurol 234: 427–429, 1987.

    Article  PubMed  CAS  Google Scholar 

  101. Conway B, Halliday WC, Brunham RD: Human immunodeficiency virus-associated progressive multifocal leukoencephalopathy: Apparent response to 3′-azido-3′-deoxythymidine. Rev Infect Dis 12: 479–482, 1990.

    Article  PubMed  CAS  Google Scholar 

  102. O’Riordan T, Daly PA, Hutchinson M, et al: Progressive multifocal leukoencephalopathy—Remission with cytarabine. J Infect 20: 51–54, 1990.

    Article  PubMed  Google Scholar 

  103. Lidman C, Lindquist L, Mathiesen T, et al: Progressive multifocal leukoencephalopathy in AIDS (letter). AIDS 5: 1039–1041, 1991.

    Article  PubMed  CAS  Google Scholar 

  104. Portegies P, Algra PR, Hollak CE, et al: Response to cytarabine in progressive multifocal leukoencephalopathy in AIDS (letter). Lancet 337: 680–681, 1991.

    Article  PubMed  CAS  Google Scholar 

  105. Nicoli F, Chave B, Peragut JC, et al: Efficacy of cytarabine in progressive multifocal leukoencephalopathy in AIDS (letter; comment). Lancet 339: 306, 1992.

    Article  PubMed  CAS  Google Scholar 

  106. Smith CR, Sima AA, Salit IE, et al: Progressive multifocal leukoencephalopathy: Failure of cytarabine therapy. Neurology 32: 200–203, 1982.

    PubMed  CAS  Google Scholar 

  107. Gardner SD, Field AM, Coleman DV, et al: New human papovavirus (BK) isolated from urine after renal transplantation. Lancet 1: 1253–1257, 1971.

    Article  PubMed  CAS  Google Scholar 

  108. Coleman DV, MacKenzie EFD, Gardner SD, et al: Human polymavirus (BK) infection and ureteric stenosis in renal allograft recipients. J Clin Pathol 31: 338–347, 1978.

    Article  PubMed  CAS  Google Scholar 

  109. Lecatsas A, Prozesky OW, Van Wyk J, et al: Papovavirus in urine after renal transplantation. Nature (Lond) 241: 343–344, 1973.

    Article  CAS  Google Scholar 

  110. Andrews C, Shah KV, Rubin RH, et al: BK papovavirus in renal transplant recipients: Contribution of donor kidneys. J Infect Dis 145: 276, 1982.

    Article  PubMed  CAS  Google Scholar 

  111. Cheeseman SH, Black PH, Rubin RH, et al: Interferon and BK papovavirus. Clinical and laboratory studies. Infect Dis 41: 157–161, 1980.

    Article  Google Scholar 

  112. Rosen S, Harmon W, Krensky AM, et al: Tubulointerstitial nephritis associated with polyomavirus (BK type) infection. N Engl J Med 308: 1192–1196, 1983.

    Article  PubMed  CAS  Google Scholar 

  113. Gross G, Pfister H, Hagedorn M, et al: Correlation between human papillomavirus (HPV) type and histology of warts. J Invest Dermatol 78: 160–164, 1982.

    Article  PubMed  CAS  Google Scholar 

  114. Favre M, Obalek S, Jablonska S, et al: Human papillomavirus type 49, a type isolated from flat warts of renal transplant patients. J Virol 63: 4909, 1989.

    PubMed  CAS  Google Scholar 

  115. Morrison WL: Viral warts, herpes simplex, and herpes zoster in patients with secondary immune deficiencies and neoplasms. Br J Dermatol 92: 625–630, 1975.

    Article  Google Scholar 

  116. Barnett N, Mak H, Winkelstein J: Extensive verrucosis in primary immunodeficiency diseases. Arch Dermatol 119: 5–7, 1983.

    Article  PubMed  CAS  Google Scholar 

  117. Spencer ES, Anderson HK: Clinically evident, non-terminal infections with herpesviruses and the wart virus in immuno-suppressed renal allograft recipients. Br Med J 3: 251–254, 1970.

    Article  PubMed  CAS  Google Scholar 

  118. Perry TL, Harman L Jr: Warts in diseases with immune defects. Cutis 13: 359–362, 1974.

    Google Scholar 

  119. Mullen DL, Silverberg SG, Penn I, et al: Squamous cell carcinoma of the skin and lip in renal homograft recipients. Cancer 37: 729–734, 1976.

    Article  PubMed  CAS  Google Scholar 

  120. Barr BB, Benton EC, McLaren K, et al: Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1: 124–129, 1989.

    Article  PubMed  CAS  Google Scholar 

  121. Matorras R, Ariceta JM, Rementeria A, et al: Human immunodeficiency virus-induced immunosuppression: A risk factor for human papillomavirus infection. Am J Obstet Gynecol 164: 42–44, 1991.

    PubMed  CAS  Google Scholar 

  122. Henry MJ, Stanley MW, Cruikshank S, et al: Association of human immunodeficiency virus-induced immunosuppression with human papillomavirus infection and cervical intraepithelial neoplasia. Am J Obstet Gynecol 160: 352–353, 1989.

    PubMed  CAS  Google Scholar 

  123. Alloub MI, Barr BB, McLaren KM, et al: Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. Br Med J 298: 153–156, 1989.

    Article  CAS  Google Scholar 

  124. Lane JM, Ruben FL, Abrutyn E, et al: Deaths attributable to smallpox vaccination 1959 to 1966, and 1968, JAMA 212: 441–444, 1970.

    Article  PubMed  CAS  Google Scholar 

  125. Lane JM, Ruben FL, Neff JM, et al: Complications of smallpox vaccination, 1968. II Results of the ten statewide surveys. J Infect Dis 122: 303–308, 1970.

    Article  PubMed  CAS  Google Scholar 

  126. Lane JM, Ruben RL, Neff JM, et al: Complications of smallpox vaccination, 1968: 1. National surveillance in the United States. N Engl J Med 281: 1201–1208, 1969.

    Article  PubMed  CAS  Google Scholar 

  127. Neff JM, Lane JM, Pert JH, et al: Complications of smallpox vaccination. I. National surveillance in the United States, 1963. N Engl JMed 276: 125–132, 1967.

    Article  CAS  Google Scholar 

  128. Turner W, Bauer DJ, Nimmo-Smith RH: Eczema vaccinatum treated with N-methylisatin β-thiosemicarbazone. Br Med J 1: 1317–1319, 1962.

    Article  PubMed  CAS  Google Scholar 

  129. Brainerd HD, Hanna L, Jawetz E: Methisazone in progressive vaccinia. N Engl J Med 276: 620–622, 1967.

    Article  PubMed  CAS  Google Scholar 

  130. Centers for Disease Control: Poliomyelitis Surveillance Summary. 1980–1981. CDC, Atlanta, Georgia, 1982.

    Google Scholar 

  131. Moore M, Katona P, Kaplan JE, et al: Poliomyelitis in the United States, 1969–1981. J Infect Dis 146: 558–563. 1982.

    Article  PubMed  CAS  Google Scholar 

  132. Wyatt HV: Poliomyelitis in hypogammaglobulinemics. J Infect Dis 128: 802–806, 1973.

    Article  PubMed  CAS  Google Scholar 

  133. Chang TW, Weinstein L, MacMahon HE. Paralytic poliomyelitis in a child with hypogammaglobulinemia: Probable implications of type I vaccine strain. Pediatrics 37: 630–636, 1966.

    PubMed  CAS  Google Scholar 

  134. Riker JB, Brandt CD, Chandra R, et al: Vaccine-associated poliomyelitis in a child with thymic abnormality. Pediatrics 48: 923–929, 1971.

    PubMed  CAS  Google Scholar 

  135. Feigin RD, Guggenheim MA, Johnson SD: Vaccine related paralytic poliomyelitis in an immunodeficient child. J Pediatr 79: 642–647, 1971.

    Article  PubMed  CAS  Google Scholar 

  136. Saulsbury FT, Winkelstein JA, Davis LE, et al: Combined immunodeficiency and vaccine related poliomyelitis in a child with cartilage hair hypoplasia. J Pediatr 86: 868–872, 1975.

    Article  PubMed  CAS  Google Scholar 

  137. Centers for Disease Control: Neurotropic Disease Surveillance. Annual Summary 1969. U.S. Department of Health, Education and Welfare, Public Health Service, Washington, DC, 1969.

    Google Scholar 

  138. Lopez C, Biggar WD, Park BH, et al: Nonparalytic poliovirus infections in patients with severe combined immunodeficiency disease. J Pediatr 84: 447–502, 1974.

    Google Scholar 

  139. Davis LE, Bodian D, Price D, et al: Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N Engl J Med 297: 241–245, 1977.

    Article  PubMed  CAS  Google Scholar 

  140. Wright PF, Hatch MH, Kasselberg AG, et al: Vaccine associated poliomyelitis in a child with sex linked agammaglobulinemia. J Pediatr 91: 408–412, 1977.

    Article  PubMed  CAS  Google Scholar 

  141. Ziegler JB, Penny R: Fatal echo 30 virus infection and amyloidosis in X-linked hypogammaglobulinemia. Clin Immunol Immunopathol 3: 347–352, 1975.

    Article  PubMed  CAS  Google Scholar 

  142. Bardelas JA, Winkelstein JA, Seto DSY, et al: Fatal ECHO 24 infection in a patient with hypogammaglobulinemia: Relationship to dermatomyositis-like syndrome. J Pediatr 90: 396–399, 1977.

    Article  PubMed  CAS  Google Scholar 

  143. Wilfert CM, Buckley RH, Mohanakumar T, et al: Persistent and fatal central nervous system echovirus infections in agammaglobulinemia. N Engl J Med 296: 1485–1489, 1977.

    Article  PubMed  CAS  Google Scholar 

  144. Webster ADB, Tripp JH, Hayward AR, et al: Echovirus encephalitis and myositis in primary immunoglobulin deficiency. Arch Dis Child 53: 33–37, 1978.

    Article  PubMed  CAS  Google Scholar 

  145. Bodensteiner JB, Morris HH, Howell JT, et al: Chronic echo type 5 virus meningoencephalitis in X-linked hypogammaglobulinemia: Treatment with immune plasma. Neurology (NY) 29: 815–819, 1979.

    CAS  Google Scholar 

  146. Weiner LS, Howell JT, Langford MP, et al: Effect of specific antibodies on chronic echovirus type 5 encephalitis in a patient with hypogammaglobulinemia. J Infect Dis 140: 858–863, 1979.

    Article  PubMed  CAS  Google Scholar 

  147. Mease PJ, Ochs HD, Wedgewood RJ: Successful treatment of echovirus meninogoencephalitis and myositis-fascitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia. N Engl J Med 304: 1278–1281, 1981.

    Article  PubMed  CAS  Google Scholar 

  148. Hodes DS, Espinoza DV: Temperature sensitivity of isolate of echovirus type II causing chronic meningoencephalitis in an agammaglobulinemic patient. J Infect Dis 144: 377, 1981.

    Article  PubMed  CAS  Google Scholar 

  149. Wagner DK, Marti GE, Jaffe ES, et al: Lymphocyte analysis in a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency after development of echovirus dermatomyositis and meningoencephalitis. Int Arch Allergy Appl Immunol 89: 143–148, 1989.

    Article  PubMed  CAS  Google Scholar 

  150. Van Maldergem L, Mascart F, Ureel D, et al: Echovirus meningoencephalitis in X-linked hypogammaglobulinemia. Acta Paediatr Scand 78: 325–326, 1989.

    Article  PubMed  Google Scholar 

  151. Smith JK, Chi DS, Guarderas J, et al: Disseminated echovirus infection in a patient with multiple myeloma and a functional defect in complement. Treatment with intravenous immunoglobulin. Arch Intern Med 149: 1455–1457, 1989.

    Article  PubMed  CAS  Google Scholar 

  152. Biggs DD, Toorkey BC, Carrigan DR, et al: Disseminated echo-virus infection complicating bone marrow transplantation. Am J Med 88: 421–425, 1990.

    Article  PubMed  CAS  Google Scholar 

  153. Rotbart HA, Kinsella JP, Wasserman RL: Persistent enterovirus infection in culture-negative meningoencephalitis: Demonstration by enzymatic RNA amplification. J Infect Dis 161: 787–791, 1990.

    Article  PubMed  CAS  Google Scholar 

  154. Misbah SA, Spickett GP, Ryba PC, et al: Chronic enteroviral meningoencephalitis in agammaglobulinemia: Case report and literature review. J Clin Immunol 12: 266–270, 1992.

    Article  PubMed  CAS  Google Scholar 

  155. Cooper JB, Pralt WR, English BK, et al: Coxsackievirus B3 producing fatal meningoencephalitis in a patient with X-linked agammaglobulinemia. Am J Dis Child 137: 82–83, 1983.

    PubMed  CAS  Google Scholar 

  156. Hertel NT, Pedersen FK, Heilmann C: Coxsackie B3 virus encephalitis in a patient with agammaglobulinemia. Eur J Pediatr 148: 642–643, 1989.

    Article  PubMed  CAS  Google Scholar 

  157. Woods MG, Diana GD, Rogge MC, et al: In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug. Antimicrob Agents Chemother 33: 2069–2074, 1989.

    PubMed  CAS  Google Scholar 

  158. See DM, Tilles JG: Treatment of coxsackievirus A9 myocarditis in mice with WIN 54954. Antimicrob Agents Chemother 36: 425–428, 1992.

    PubMed  CAS  Google Scholar 

  159. Townsend TR, Yolken RH, Bishop CA, et al: Outbreak of coxsackie A1 gastroenteritis: A complication of bone marrow transplantation. Lancet 1: 820–823, 1982.

    Article  PubMed  CAS  Google Scholar 

  160. Yolken RH, Bishop CA, Townsend TA, et al: Infectious gastroenteritis in bone marrow transplant recipients. N Engl J Med 306: 1009–1012, 1982.

    Article  Google Scholar 

  161. Krugman S: Present status of measles and rubella immunization in the United States: A medical progress report. J Pediatr 90: 1–12, 1977.

    Article  PubMed  CAS  Google Scholar 

  162. Smithwick EM, Berkovich S: In vitro suppression of lymphocyte response to tuberculosis by live measles virus. Proc Soc Exp Biol Med 123: 276–278, 1966.

    PubMed  CAS  Google Scholar 

  163. Schooley RT, Hirsch MS, Colvin RB, et al: Association of herpesvirus infections with T-lymphocyte subset alterations glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med 308: 313–318, 1983.

    Article  Google Scholar 

  164. Blumberg RS, Schooley RT: Lymphocyte markers and infectious diseases. Semin Hematol 22: 81–114, 1985.

    PubMed  CAS  Google Scholar 

  165. Enders JF, McCarthy K, Mitus A, et al: Isolation of measles virus at autopsy in cases of giant cell pneumonia without rash. N Engl J Med 261: 875–881, 1959.

    Article  PubMed  CAS  Google Scholar 

  166. Breitfeld V, Hashida Y, Sherman FE, et al: Fatal measles infection in children with leukemia. Lab Invest 29: 279–291, 1973.

    Google Scholar 

  167. Kaplan LJ, Daum RS, Smaron M, et al: Severe measles in immunocompromised patients. JAMA 267: 1237–1241, 1992.

    Article  PubMed  CAS  Google Scholar 

  168. Gray MM, Hann IM, Glass S, et al: Mortality and morbidity caused by measles in children with malignant disease attending four major treatment centers: A retrospective view. Br Med J 295: 19–22, 1987.

    Article  CAS  Google Scholar 

  169. Kernahan J, McQuillin J, Craft AW: Measles in children who have malignant disease. Br Med J 295: 15–18, 1987.

    Article  CAS  Google Scholar 

  170. Sension MG, Quinn TC, Markowitz LE, et al: Measles in hospitalized African children with human immunodeficiency virus. Am J Dis Child 142: 1271–1272, 1988.

    PubMed  CAS  Google Scholar 

  171. Aicardi J, Goutieres F, Arseni-Nunes ML, et al: Acute measles encephalitis in children with immunosuppression. Pediatrics 59: 232–239, 1977.

    PubMed  CAS  Google Scholar 

  172. Simpson R, Eden OB: Possible interferon response in a child with measles encephalitis during immunosuppression. Scand J Infect Dis 16: 315–319, 1984.

    Article  PubMed  CAS  Google Scholar 

  173. Gibbs FA, Gibbs EL, Carpenter PR, et al: Electrocephalographic changes in uncomplicated childhood diseases. JAMA 171: 1050–1059, 1959.

    Article  CAS  Google Scholar 

  174. Meulen VT, Muller D, Kackell Y, et al: Isolation of infectious measles virus in measles encephalitis. Lancet 2: 1172–1175, 1972.

    Article  PubMed  Google Scholar 

  175. Shaffer MF, Rake G, Hodes HL: Isolation of virus from a patient with fatal encephalitis complicating measles. Am J Dis Child 64: 815, 1982.

    Google Scholar 

  176. Connolly JH, Allen IV, Hurwitz LJ, et al: Measles virus antibody and antigen in subacute sclerosing panencephalitis. Lancet 1: 542–544, 1967.

    Article  PubMed  CAS  Google Scholar 

  177. Barbosa LH, Fucciloo DA, Sever JL, et al: Subacute sclerosing panencephalitis: Isolation of measles virus from a brain biopsy. Nature (Lond.) 221: 974, 1969.

    Article  Google Scholar 

  178. Editorial: Measles encephalitis during immunosuppressive treatment. Br Med J 1: 1552, 1976.

    Google Scholar 

  179. Murphy JV, Yunis EJ: Encephalopathy following measles infection in children with chronic illness. J Pediatr 88: 937–942, 1976.

    Article  PubMed  CAS  Google Scholar 

  180. Agamanolis DP, Tun JS, Parker DL: Immunosuppressive measles encephalitis in a patient with a renal transplant. Arch Neurol 36: 686–690, 1979.

    Article  PubMed  CAS  Google Scholar 

  181. Pullen CR, Noble TC, Scott DJ, et al: Atypical measles infections in leukaemic children on immunosuppressive treatment. Br Med J 1: 1562–1565, 1976.

    Article  Google Scholar 

  182. Olding-Stenkvist E, Forsgren M, Henley D, et al: Measles encephalopathy during immunosuppression: Failure of interferon treatment. Scand J Infec Dis 14: 1–4, 1982.

    CAS  Google Scholar 

  183. Fouillard L, Mouthon L, Laporte JP, et al: Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: A report of three cases and review. Bone Marrow Transplant 9: 97–100, 1992.

    PubMed  CAS  Google Scholar 

  184. Win N, Mitchell D, Pugh S, et al: Successful therapy with ribavirin of late onset respiratory syncytial virus pneumonitis complicating allogeneic bone transplantation. Clin Lab Haematol 14: 29–32, 1992.

    PubMed  CAS  Google Scholar 

  185. Mitus A, Holloway A, Evans AE, et al: Attenuated measles vaccine in children with leukemia. Am J Dis Child 103: 243–248, 1962.

    Google Scholar 

  186. Glezen WP, Denhy FW: Epidemiology of acute lower respiratory disease in children. N Engl J Med 288: 498–505, 1973.

    Article  PubMed  CAS  Google Scholar 

  187. Hall CB, Geiman JM, Biggar R, et al: Respiratory syncytial virus infections within families. N Engl J Med 294: 414–419, 1976.

    Article  PubMed  CAS  Google Scholar 

  188. Hall GB, Douglas RG Jr: Modes of transmission of respiratory syncytial virus. J Pediatr 99: 100–103, 1981.

    Article  PubMed  CAS  Google Scholar 

  189. Hall CB: Nosocomial viral respiratory infections. Perennial weeds on pediatric wards. Am J Med 70: 670–677, 1981.

    Article  PubMed  CAS  Google Scholar 

  190. Sims DG, Downham MAPS, Webbs JKG, et al: Hospital cross-infection on children’s wards with respiratory syncytial virus and the role of adult carriage. Acta Paediatr Scand 64: 541–545, 1975.

    Article  PubMed  CAS  Google Scholar 

  191. MacDonald NE, Hall CB, Suffin SC, et al: Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 307: 397–400, 1982.

    Article  PubMed  CAS  Google Scholar 

  192. Johnson RA, Prince GA, Suffin SC, et al: Respiratory syncytial virus infection in cyclophosphamide-treated cotton rats. Infect Immun 37: 369–373, 1982.

    PubMed  CAS  Google Scholar 

  193. Milder JE, McDearmon SC, Walzer PD: Presumed respiratory syncytial virus pneumonia in an adolescent compromised host. South Med J 72: 1195–1198, 1979.

    Article  PubMed  CAS  Google Scholar 

  194. Hall CB, MacDonald NE, Klemperer MR, et al: Respiratory syncytial virus in immunosuppressed children. Pediatr Res 15: 613, 1981.

    Google Scholar 

  195. Rodriguez WJ, Kim HW, Arrobio JO, et al: Clinical features of acute gastroenteritis associated with human reovirus like agent in infants and young children. J Pediatr 91: 188–193, 1977.

    Article  PubMed  CAS  Google Scholar 

  196. Carlson JAK, Middleton PJ, Ssymanski MT, et al: Fatal rotavirus gastrointeristis. An analysis of 21 cases. Am J Dis Child 132: 477–479, 1978.

    PubMed  CAS  Google Scholar 

  197. Kapikian AZ, Wyatt RG, Levin MM, et al: Oral administration of human rotavirus to volunteers: Induction of illness and correlates of resistance. J Infect Dis 147: 95–106, 1983.

    Article  PubMed  CAS  Google Scholar 

  198. Saulsbury FT, Winklestein JA, Yolken RH: Chronic rotavirus infection in immunodeficiency. J Pediatr 97: 61–65, 1980.

    Article  PubMed  CAS  Google Scholar 

  199. Jarvis WR, Middleton PJ, Gilford EW: Significance of viral infections in severe combined immunodeficiency disease. Pediatr Infect Dis 2: 187–192, 1983.

    Article  PubMed  CAS  Google Scholar 

  200. Flewett TH, Bryden AS, Davies H: Virus particles in gastroenteritis. Lancet 2: 1497, 1973.

    Article  PubMed  CAS  Google Scholar 

  201. Kapikian AZ, Kim HW, Wyatt RG, et al: Reovirus like agent in stools: association with infantile diarrhea and development of serologic tests. Science 185: 1049–1053, 1974.

    Article  PubMed  CAS  Google Scholar 

  202. Brendt CD, Kim HW, Rodriguez WH, et al: Comparison of direct electron microscopy, immune electron microscopy, immune electron microscopy, and rotavirus enzyme linked immunosorbent assay for detection of gastroenteritis viruses in children. J Clin Microbiol 13: 976–988, 1981.

    Google Scholar 

  203. Middleton PJ, Holdaway MD, Petore M, et al: Solid phase radio-immunoassay for the detection of rotavirus. Infect Immun 16: 439–444, 1977.

    PubMed  CAS  Google Scholar 

  204. Yolken RH, Kim HW, Clem T, et al: Enzyme linked immunosorbent assay (ELIS A) for detection of human reovirus-like agent of infantile gastroenteritis. Lancet 2: 263–267, 1977.

    Article  PubMed  CAS  Google Scholar 

  205. Kim HW, Brandt CD, Kaoikain AZ, et al: Human reovirus like agent (HRLVA) infection. Occurrence in adult contacts of pediatric patients with gastroenteritis. JAMA 238: 404–407, 1977.

    Article  PubMed  CAS  Google Scholar 

  206. Halvrsrud J, Ostavik I: An epidemic of rotavirus associated gastroenteritis in a nursing home for the elderly. Scand J Infect Dis 12: 161–164, 1980.

    Google Scholar 

  207. Holzel H, Cubett DW, McSwiggan DA, et al: An outbreak of rotavirus infection among adults in a cardiology ward. J Infect 2: 33, 1980.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado, 80262, USA

    Robert T. Schooley

Authors
  1. Robert T. Schooley
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Boston, Massachusetts, USA

    Robert H. Rubin M.D. (Chief of Transplantation Infectious Disease, Director of the Center for Experimental Pharmacology and Therapeutics) (Chief of Transplantation Infectious Disease, Director of the Center for Experimental Pharmacology and Therapeutics)

  2. Division of Health Sciences and Technology, Harvard University-Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

    Robert H. Rubin M.D. (Chief of Transplantation Infectious Disease, Director of the Center for Experimental Pharmacology and Therapeutics) (Chief of Transplantation Infectious Disease, Director of the Center for Experimental Pharmacology and Therapeutics)

  3. Pacific California Medical Center, San Francisco, California, USA

    Lowell S. Young M.D. (Director of Kuzell Institute for Arthritis and Infectious Diseases, Chief of Division of Infectious Diseases) (Director of Kuzell Institute for Arthritis and Infectious Diseases, Chief of Division of Infectious Diseases)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Plenum Publishing Corporation

About this chapter

Cite this chapter

Schooley, R.T. (1994). Morbidity in Compromised Patients Related to Viruses Other Than Herpes Group and Hepatitis Viruses. In: Rubin, R.H., Young, L.S. (eds) Clinical Approach to Infection in the Compromised Host. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2490-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2490-8_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-44617-7

  • Online ISBN: 978-1-4615-2490-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation